Social Media RSS Feed
December 12, 2013
December 10, 2013Dr. Alain Cribier Receives Texas Heart Institute's Ray
C. Fish Award for scientific achievement
St. Luke’s Medical Center and the Texas Heart Institute first in Houston to implement new approach for treating heart failure.
- previously tested in Europe - is part of a global
study to determine its safety and efficacy. INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) will evaluate the
system’s ability to reduce hospitalization and death among patients with HF, and whether combined treatment with CardioFit and prescription
drug therapy is more effective than drug therapy alone.
Pioneer of heart
valve replacement with catheter (TAVR
), Dr. Cribier became widely recognized for performing the first balloon dilatation of the aortic valve in 1985, and after 10 years of research, the first implantation of an aortic valve prosthesis using cardiac catheterization techniques in 2002.
December 2, 2013
Learning to Defuse the Aorta
Helping kids with Marfan syndrome; detecting and treating enlarged aortas
When Dr. Hal Dietz arrived at Johns Hopkins University in the 1980s, he became obsessed with helping children with Marfan syndrome, a rare and often fatal disorder that can cause the aorta, the large blood vessel that carries blood from the heart, to grow and grow until it bursts.... That journey has led to surprising discoveries about Marfan's causes and a soon-to-be published clinical trial of a drug that may help its sufferers.
Time is of the essence. Patients whose aortas are breaking apart "all need immediate treatment," said Dr. Scott A. LeMaire, a professor of surgery and of molecular physiology and biophysics at the Baylor College of Medicine [and a member of the Texas Heart Institute professional staff].
— New York Times Science.
Learn more about Marfan Syndrome and Aneurysms & Dissections.
November 26, 2013 First 4 Patients Enrolled in Study to Test Dissolving Device in Treatment of Heart Disease
St. Luke's Medical Center, home of the Texas Heart Institute, recently enrolled 4 patients with coronary artery disease (CAD), into a study to evaluate the potential benefits of a dissolving device, similar to a metallic stent. THI's Dr. Emerson Perin explains. — St. Luke's Medical Center news
See a previous interview with Dr. Perin. — Houston Chronicle.
November 24, 2013
Cholesterol battle takes a new turn
Some of the top cardiologists in the country are having a public disagreement about who should take statin drugs and how to calculate the risk of heart attack or stroke. Dr. Jim Willerson, president and medical director of the Texas Heart Institute, said qualified doctors won't reactively upend the way they're treating patients anyway. — Houston Chronicle Health.
Statins help heart health, but come with side effects
... and, Dr. Willerson reviews the most common side effects from taking statins, which may include muscle pain, elevated liver enzymes, risk of diabetes, and mental confusion. — Houston Chronicle.
Statin Recommendations Focus Less on Lab Numbers, More on Lifestyle
— Texas Medical Center News
November 21, 2013BCM, Texas Heart Institute Report Breakthrough In Adult Heart Repair
Researchers led by Dr. James Martin, director, Cardiomyocyte Renewal Laboratory at THI, reported new discoveries into how cardiologists can dramatically improve heart repair, particularly after a heart attack. Read article on Bio News Texas website
> News archive